Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment

BACKGROUND: The irinotecan-induced phosphokinome changes in colorectal cancer (CRC) cells were used to guide the selection of targeted agents to be tested in combination with irinotecan. METHODS: Phosphokinome profiling with peptide arrays of tumour samples from nude mice xenografted with HT29 cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosi, Diego, Pérez-Gracia, Esther, Atis, Salima, Vié, Nadia, Combès, Eve, Gabanou, Mélissa, Larbouret, Christel, Jarlier, Marta, Mollevi, Caroline, Torro, Adeline, Del Rio, Maguy, Martineau, Pierre, Gongora, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090616/
https://www.ncbi.nlm.nih.gov/pubmed/30103709
http://dx.doi.org/10.1186/s12885-018-4712-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090616/
https://www.ncbi.nlm.nih.gov/pubmed/30103709
http://dx.doi.org/10.1186/s12885-018-4712-z

Ejemplares similares